Background Tuberculosis (TB) is the most common opportunistic infection and the leading
cause of death in people living with HIV (PLHIV). HIV-infected children are at a higher risk of …

Background Data to inform the switch from a ritonavir-boosted protease inhibitor (PI) to
dolutegravir in patients living with human immunodeficiency virus (HIV) infection who do not …

Early mortality rates after initiating antiretroviral therapy (ART) are high in sub-Saharan
Africa. We examined whether serum chemistries at ART initiation predicted mortality among …

Objective Hypertension affects 23% of Kenyans and is the most prevalent modifiable risk
factor for cardiovascular disease. Despite this, hypertension awareness and treatment …

Background Intrapartum and neonatal single-dose nevirapine (NVP) reduces the risk of
mother-to-child HIV transmission but also induces viral resistance to non-nucleoside reverse …

Evolution and natural selection have endowed animal venoms, including scorpion venoms,
with a wide range of pharmacological properties. Consequently, scorpions, their venoms …

Background Clinical trials were conducted to assess the feasibility of using a cell phone text
messaging-based system to follow up Human Immunodeficiency Virus (HIV) infected …

Background Understanding trends in patient profiles and identifying predictors for adverse
outcomes are key to improving the effectiveness of HIV care and treatment programs …

Background: Women's knowledge and access to reproductive health services improves their
ability to safely achieve their required fertility and reduces maternal and infant morbidity and …

Collecting self-reported data on adherence to highly active antiretroviral therapy (HAART)
can be complicated by patients' reluctance to report poor adherence. The timeliness with …